IvyRock Asset Management »

Summit Therapeutics shares owned by IvyRock Asset Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by IvyRock Asset Management from 13F filings

Historical chart of IvyRock Asset Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by IvyRock Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by IvyRock Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.8M 92k 19.29
2024-12-31 $3.0M 167k 17.85

More positions owned by IvyRock Asset Management

Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Zai Lab Adr (ZLAB)
Spdr Gold Tr Gold Shs (GLD)
Bloom Energy Corp Com Cl A (BE)
Direxion Shs Etf Tr Daily S&p Biotch (LABU)
So Young International Sponsored Ads (SY)
Microsoft Corporation (MSFT)
Arrowhead Pharmaceuticals (ARWR)
Advanced Micro Devices (AMD)
Cisco Systems (CSCO)
Intellia Therapeutics (NTLA)

View all positions for IvyRock Asset Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics